Koninklijke Philips NV (NYSE:PHG)

$ 25.82 0.43 (1.69%) Market Cap: 24.06 Bil Enterprise Value: 30.72 Bil PE Ratio: 0 PB Ratio: 1.98 GF Score: 72/100

Q3 2024 Koninklijke Philips NV Earnings Call Transcript
Oct 28, 2024

$26.62 (-15.95%)

Earnings
Q2 2024 Koninklijke Philips NV Earnings Call Transcript
Jul 29, 2024

$29.15 (+13.16%)

Earnings
Q1 2024 Koninklijke Philips NV Earnings Call Transcript
Apr 29, 2024

$25.83 (+26.77%)

Earnings
Q4 2023 Koninklijke Philips NV Earnings Call Transcript
Jan 29, 2024

$20.82 (-5.40%)

Earnings
Q3 2023 Koninklijke Philips NV Earnings Call Transcript
Oct 23, 2023

$18.21 (+3.18%)

Earnings
Q2 2023 Koninklijke Philips NV Earnings Call Transcript
Jul 24, 2023

$20.8 (-6.68%)

Earnings
Koninklijke Philips NV Update on Philips Respironics' PE-PUR Sound Abatement Foam Test and Research Program Call Transcript
May 16, 2023
Q1 2023 Koninklijke Philips NV Earnings Call Transcript
Apr 24, 2023

$20.1 (+14.14%)

Earnings
Q4 2022 Koninklijke Philips NV Earnings Call Transcript
Jan 30, 2023

$16.65 (+5.89%)

Earnings
Koninklijke Philips NV to Discuss Update on Philips Respironics' PE-PUR Sound Abatement Foam Test and Research Program Call Transcript
Dec 21, 2022
Q3 2022 Koninklijke Philips NV Earnings Call Transcript
Oct 24, 2022

$11.93 (-1.38%)

Earnings
Koninklijke Philips NV Provides Update on Its Financial Performance in Q3 2022 and Full-year Outlook Call Transcript
Oct 12, 2022
Q2 2022 Koninklijke Philips NV Earnings Call Transcript
Jul 25, 2022

$19.02 (-7.18%)

Earnings
Koninklijke Philips NV Provides Update on Philips Respironics' PE-PUR Sound Abatement Foam Test and Research Program Call Transcript
Jun 28, 2022
Koninklijke Philips NV Annual Shareholders Meeting Transcript
May 10, 2022
Q1 2022 Koninklijke Philips NV Earnings Call Transcript
Apr 25, 2022

$24.91 (-11.31%)

Earnings
Q4 2021 Koninklijke Philips NV Earnings Call Transcript
Jan 24, 2022

$29.74 (-2.99%)

Earnings
Preliminary Q4 2021 Koninklijke Philips NV Earnings Call Transcript
Jan 12, 2022

$30.63 (-14.65%)

Earnings
Q3 2021 Koninklijke Philips NV Earnings Call Transcript
Oct 18, 2021

$39.99 (-3.07%)

Earnings
Q2 2021 Koninklijke Philips NV Earnings Call Transcript
Jul 26, 2021

$42.71 (-3.75%)

Earnings
Koninklijke Philips NV Annual Shareholders Meeting Transcript
May 06, 2021
Q1 2021 Koninklijke Philips NV Earnings Call Transcript
Apr 26, 2021

$54.41 (-3.80%)

Earnings
Q4 2020 Koninklijke Philips NV Earnings Call Transcript
Jan 25, 2021

$52.77 (+2.61%)

Earnings
Koninklijke Philips NV to Acquire BioTelemetry Inc Call Transcript
Dec 18, 2020
Koninklijke Philips NV Virtual Capital Markets Day Transcript
Nov 06, 2020
Q3 2020 Koninklijke Philips NV Earnings Call Transcript
Oct 19, 2020

$45.82 (+1.41%)

Earnings
Q2 2020 Koninklijke Philips NV Earnings Call Transcript
Jul 20, 2020

$48.22 (+4.70%)

Earnings
Koninklijke Philips NV Extraordinary Shareholders Meeting Transcript
Jun 26, 2020
Koninklijke Philips NV Annual Shareholders Meeting Transcript
Apr 30, 2020
Q1 2020 Koninklijke Philips NV Earnings Call Transcript
Apr 20, 2020

$38.86 (+4.16%)

Earnings
Q4 2019 Koninklijke Philips NV Earnings Call Transcript
Jan 28, 2020

$43.39 (-1.79%)

Earnings
Q3 2019 Koninklijke Philips NV Earnings Call Transcript
Oct 28, 2019

$39.35 (-1.39%)

Earnings
Preliminary Q3 2019 Koninklijke Philips NV Earnings Call Transcript
Oct 10, 2019

$38.02 (-8.25%)

Earnings
Q2 2019 Koninklijke Philips NV Earnings Call Transcript
Jul 22, 2019

$41.9 (+6.14%)

Earnings
Q1 2019 Koninklijke Philips NV Earnings Call Transcript
Apr 29, 2019

Earnings

Koninklijke Philips NV to Discuss Update on Philips Respironics' PE-PUR Sound Abatement Foam Test and Research Program Call Transcript

Dec 21, 2022 / 08:00AM GMT

Release Date Price: $12.98 (+6.29%)

Transcript

Unidentified Company Representative

Thank you, and good morning, everyone. Welcome to today's conference call to update you on the Philips Respironics test and research program for the polyester polyurethane sound abatement foam. We appreciate that you could join our call on short notice. I'm here with our CEO, Roy Jakobs; our CFO, Abhijit Bhattacharya; and Steve Klink, who is the spokesperson for the test and research program. The press release, slide deck, infographic and frequently asked questions on the topic were published at 8:00 a.m. CET on our Investor Relations website this morning. The full transcript of this call will be made available on the website as well. Over to you, Roy.

Roy Jakobs

Koninklijke Philips N.V. - CEO & President

Hello, everyone, and thank you for joining us this morning. Today, we are providing an update on the latest testing results regarding the safety of the sleep therapy devices and ventilators affected by the June 2021 field safety notice. Before I discuss the results in more detail, I would like to reiterate how important

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.